The Oncology Institute Stock Forecast

Buy candidate since Aug 07, 2026

The The Oncology Institute, Inc. stock price gained 28.06% on the last trading day (Friday, 7th Aug 2026), rising from $4.99 to $6.39. During the last trading day the stock fluctuated 17.11% from a day low at $6.02 to a day high of $7.05. The price has been going up and down for this period, and there has been a 28.31% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 5 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $42.19 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $6.68 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 25.98% during the next 3 months and, with a 90% probability hold a price between $6.21 and $8.42 at the end of this 3-month period.

TOI Signals & Forecast

The The Oncology Institute, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $5.23 and $5.38. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 33.96%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for The Oncology Institute, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.39 and $5.26. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, The Oncology Institute, Inc. finds support just below today's level at $5.39. If this is broken, then the next support from accumulated volume will be at $5.26 and $5.07.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.03 between high and low, or 17.11%. For the last week, the stock has had daily average volatility of 7.60%.

Our recommended stop-loss: $6.15 (-3.74%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (TOI) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect The Oncology Institute, Inc. to open at $6.49, and during the day (based on 14 day Average True Range), to move between $6.16 and $6.62, which gives a possible trading interval of +/-$0.469 (+/-7.62%) up or down from last closing price. If The Oncology Institute, Inc. takes out the full calculated possible swing range there will be an estimated 7.62% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $5.39, some $1.00 (15.65%) from the current price of $6.39, our system finds the risk reward attractive.

Is The Oncology Institute, Inc. stock A Buy?

The Oncology Institute, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Buy candidate.

Current score: 5.292 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $6.49 ( 1.51%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk